Company: CGC
Filing Date: 2025-08-29
Form Type: 8-K
Source: 0001104659-25-085779
Chunk: 2

Company: Canopy Growth Corp
Filing Date: 2025-08-29
Form: 8-K
Item: Item 8.01
Chunk 2
---
 any other sales method
used by the Canadian Agent. The Agents may also sell the Common Shares by any other method agreed by the Company and the applicable Agent
and permitted by applicable law, including, without limitation, as block transactions. Actual sales of Common Shares pursuant to the Equity
Distribution Agreement will depend on a variety of factors to be determined by the Company from time to time, including (among others)
market conditions, the trading price of the Common Shares, capital needs and determinations by the Company of the appropriate sources
of funding for the Company.

Subject to the terms and conditions of the Equity
Distribution Agreement, the Agents will use their commercially reasonable efforts to sell the Common Shares from time to time, as sales
agents, based upon the Company’s instructions.

The Company has no obligation to sell any of the
Common Shares and may at any time suspend offers under the Equity Distribution Agreement, and either the Company or the Agents may terminate
the Equity Distribution Agreement at any time. The Equity Distribution Agreement contains customary representations, warranties and covenants
of the Company, indemnification rights and obligations of the parties and termination provisions. The
representations, warranties and covenants contained in the Equity Distribution Agreement were made only for purposes of the Equity Distribution
Agreement and as of specific dates, were solely for the benefit of the parties to the Equity Distribution Agreement and are subject to
certain limitations contained in the Equity Distribution Agreement. Accordingly, investors and security holders should not rely
on the representations and warranties in the Equity Distribution Agreement as characterizations of the actual state of facts.

The U. S. Offering
is being made pursuant to the Company’s shelf registration statement on Form S-3 (File No. 333-279949), filed with the
Securities and Exchange Commission (the “ SEC”) on June 5, 2024, and amended on May 29, 2025 and May 30, 2025
(as amended, the “ Registration Statement”), a base prospectus, dated June 4, 2025, included as part of the Registration
Statement, and a prospectus supplement, dated August 29, 2025 filed with the SEC pursuant to Rule 424(b)(5) on August 29,
2025. The Concurrent Canadian Offering is being madepursuant to a preliminary short form base shelf prospectus dated May 14,
2024, a (final) short form base shelf prospectus dated June 5, 2024 and a prospectus supplement